Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Applied Genetic Tech (AGTC)

Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,620
  • Shares Outstanding, K 67,632
  • Annual Sales, $ 330 K
  • Annual Income, $ -68,940 K
  • 60-Month Beta 1.59
  • Price/Sales 80.91
  • Price/Cash Flow N/A
  • Price/Book 1.51
Trade AGTC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.18
  • Most Recent Earnings $-0.33 on 05/16/22
  • Latest Earnings Date 12/06/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 143.09%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.28
  • Number of Estimates 2
  • High Estimate -0.26
  • Low Estimate -0.30
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3601 +9.30%
on 11/28/22
0.4290 -8.25%
on 11/03/22
-0.0164 (-4.00%)
since 10/28/22
3-Month
0.2303 +70.91%
on 10/12/22
0.4399 -10.53%
on 09/12/22
-0.0279 (-6.62%)
since 08/30/22
52-Week
0.2303 +70.91%
on 10/12/22
2.8250 -86.07%
on 02/10/22
-1.9864 (-83.46%)
since 11/26/21

Most Recent Stories

More News
SHAREHOLDER ALERT: Weiss Law Reminds AGTC, OYST, VLDR, and BTRS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AGTC : 0.3936 (+1.23%)
OYST : 11.17 (+0.18%)
VLDR : 1.2600 (+0.80%)
BTRS : 9.49 (-0.11%)
SHAREHOLDER ALERT: Weiss Law Investigates Applied Genetic Technologies Corporation

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Applied Genetic...

AGTC : 0.3936 (+1.23%)
APPLIED GENETIC TECHNOLOGIES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Genetic Technologies Corporation - AGTC

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

AGTC : 0.3936 (+1.23%)
APPLIED GENETIC TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Genetic Technologies Corporation - AGTC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Applied Genetic Technologies Corporation (NasdaqGM:...

AGTC : 0.3936 (+1.23%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LMST, PEBO, HVBC, MYOV, AGTC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

LMST : 23.42 (-1.39%)
PEBO : 27.09 (-1.13%)
HVBC : 34.60 (+0.03%)
MYOV : 26.98 (-0.04%)
AGTC : 0.3936 (+1.23%)
Shareholder Alert: Ademi LLP investigates whether Applied Genetic Technologies Corporation has obtained a Fair Price in its transaction with Syncona Limited

/PRNewswire/ -- Ademi LLP is investigating AGTC (NASDAQ: AGTC) for possible breaches of fiduciary duty and other violations of law in its transaction with...

AGTC : 0.3936 (+1.23%)
AGTC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Applied Genetic Technologies Corporation Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Applied Genetic Technologies Corporation (NASDAQ: AGTC) to Syncona Limited for $0.34 per share in cash plus potential...

AGTC : 0.3936 (+1.23%)
AGTC to Participate in Upcoming Investor Conferences

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq:...

AGTC : 0.3936 (+1.23%)
AGTC Receives Positive Type C Meeting Feedback from the FDA for the Company’s Design and Operating Procedures of its Planned cGMP Manufacturing Facility

— FDA feedback marks a key milestone in the construction of the facility expected to support AGTC’s pipeline, including the late-stage development and...

AGTC : 0.3936 (+1.23%)
AGTC Announces Pricing of $10 Million Underwritten Public Offering

GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq:...

AGTC : 0.3936 (+1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis...

See More

Key Turning Points

3rd Resistance Point 0.4357
2nd Resistance Point 0.4179
1st Resistance Point 0.4057
Last Price 0.3936
1st Support Level 0.3757
2nd Support Level 0.3579
3rd Support Level 0.3457

See More

52-Week High 2.8250
Fibonacci 61.8% 1.8338
Fibonacci 50% 1.5276
Fibonacci 38.2% 1.2215
Last Price 0.3936
52-Week Low 0.2303

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar